Northern Trust Corp Altimmune, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Altimmune, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 629,998 shares of ALT stock, worth $5.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

629,998

Previous 527,297 19.48%

Holding current value

$5.07 Million

Previous $3.51 Million 10.33%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$5.5 - $8.1 $564,855 - $831,878	102,701 Added 19.48%	629,998 $3.87 Million
Q2 2024 Aug 14, 2024	BUY	$5.91 - $10.23 $196,974 - $340,955	33,329 Added 6.75%	527,297 $3.51 Million
Q1 2024 May 14, 2024	BUY	$8.22 - $13.81 $165,542 - $278,119	20,139 Added 4.25%	493,968 $5.03 Million
Q4 2023 Feb 13, 2024	BUY	$2.14 - $11.62 $50,116 - $272,128	23,419 Added 5.2%	473,829 $5.33 Million
Q3 2023 Nov 13, 2023	BUY	$2.4 - $3.45 $67,137 - $96,510	27,974 Added 6.62%	450,410 $1.17 Million
Q2 2023 Aug 11, 2023	BUY	$3.45 - $5.97 $967,369 - $1.67 Million	280,397 Added 197.41%	422,436 $1.49 Million
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $8,886 - $35,696	2,121 Added 1.52%	142,039 $599,000
Q4 2022 Feb 13, 2023	BUY	$8.74 - $16.45 $249,343 - $469,302	28,529 Added 25.61%	139,918 $2.3 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $102,432 - $215,136	9,600 Added 9.43%	111,389 $1.42 Million
Q2 2022 Aug 12, 2022	SELL	$3.94 - $11.77 $1.02 Million - $3.04 Million	-258,338 Reduced 71.74%	101,789 $1.19 Million
Q1 2022 May 13, 2022	SELL	$5.9 - $9.45 $96,506 - $154,573	-16,357 Reduced 4.34%	360,127 $2.19 Million
Q4 2021 Feb 08, 2022	SELL	$8.69 - $12.48 $93,904 - $134,858	-10,806 Reduced 2.79%	376,484 $3.45 Million
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $463,650 - $924,549	55,000 Added 16.55%	387,290 $4.38 Million
Q2 2021 Aug 13, 2021	BUY	$9.85 - $16.46 $2.38 Million - $3.98 Million	241,637 Added 266.55%	332,290 $3.27 Million
Q1 2021 May 12, 2021	SELL	$12.71 - $24.31 $179,757 - $343,816	-14,143 Reduced 13.5%	90,653 $1.28 Million
Q4 2020 Feb 11, 2021	SELL	$7.84 - $14.22 $77,224 - $140,067	-9,850 Reduced 8.59%	104,796 $1.18 Million
Q3 2020 Nov 16, 2020	BUY	$9.93 - $33.26 $167,390 - $560,663	16,857 Added 17.24%	114,646 $1.51 Million
Q2 2020 Aug 14, 2020	BUY	$2.9 - $10.71 $245,908 - $908,165	84,796 Added 652.63%	97,789 $1.05 Million
Q4 2019 Feb 14, 2020	SELL	$1.53 - $2.15 $4,380 - $6,155	-2,863 Reduced 18.06%	12,993 $25,000
Q3 2019 Nov 13, 2019	BUY	$1.95 - $2.66 $30,919 - $42,176	15,856 New	15,856 $31,000

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $395M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Altimmune, Inc. Transaction History